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Abstract 
Background: Sepsis-3 definitions were published recently and validated only in high-income countries. The aim of 
this study was to assess the new criteria’s accuracy in stratifying mortality as compared to its predecessor (Sepsis-2) 
in a Brazilian public intensive care unit (ICU) and to investigate whether the addition of lactate values would improve 
stratification.
Methods: Retrospective cohort study conducted between 2010 and 2015 in a public university’s 19-bed ICU. Data 
from patients admitted to the ICU with sepsis were retrieved from a prospectively collected database. ICU mortality 
was compared across categories of both Sepsis-2 definitions (sepsis, severe sepsis and septic shock) and Sepsis-3 defi-
nitions (infection, sepsis and septic shock). Area under the receiving operator characteristic curves were constructed, 
and the net reclassification index and integrated discrimination index for the addition of lactate as a categorical vari-
able to each stratum of definition were evaluated.
Results: The medical records of 957 patients were retrieved from a prospectively collected database. Mean age 
was 52 ± 19 years, median SAPS 3 was 65 [50,79], respiratory tract infection was the most common cause (42%, 402 
patients), and 311 (32%) patients died in ICU. The ICU mortality rate was progressively higher across categories of sep-
sis as defined by the Sepsis-3 consensus: infection with no organ dysfunction—7/103 (7%); sepsis—106/419 (25%); 
and septic shock—198/435 (46%) (P < 0.001). For Sepsis-2 definitions, ICU mortality was different only across the cat-
egories of severe sepsis [43/252-(17%)] and septic shock [250/572-(44%)] (P < 0.001); sepsis had a mortality of 18/135-
(13%) (P = 0.430 vs. severe sepsis). When combined with lactate, the definitions’ accuracy in stratifying ICU mortality 
only improved with lactate levels above 4 mmol/L. This improvement occurred in the severe sepsis and septic shock 
groups (Sepsis-2) and the no-dysfunction and septic shock groups (Sepsis-3). Multivariate analysis demonstrated 
similar findings.
Conclusions: In a Brazilian ICU, the new Sepsis-3 definitions were accurate in stratifying mortality and were superior 
to the previous definitions. We also observed that the new definitions’ accuracy improved progressively with severity. 
Serum lactate improved accuracy for values higher than 4 mmol/L in the no-dysfunction and septic shock groups.
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Background
Sepsis is a well-recognized worldwide healthcare issue, 
ultimately resulting in significant mortality [1], morbidity 
and resource utilization during and after critical illness 
[2]. Initial consensus definitions relied upon the sys-
temic inflammatory response syndrome (SIRS) to infec-
tion as a fundamental aspect of sepsis definition, which 
was then stratified in severity according to the pres-
ence of organ dysfunction (severe sepsis) or vasopressor 
requirement despite adequate fluid resuscitation (septic 
shock) [3]. This had an important role in education and 
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the pathophysiological understanding of the transition 
between a homeostatic and a dys-homeostatic inflamma-
tory response that results in organ dysfunctions.
In a second consensus conference, although a new 
panel of specialists agreed that SIRS was not necessary to 
the definition of sepsis, not much was changed. The panel 
recognized several factors that could be used to identify 
patients with severe sepsis and associated with increased 
mortality, ultimately leading to important efforts for the 
early recognition and treatment of severe sepsis and sep-
tic shock. This consensus also developed the PIRO con-
cept (predisposition, infection, response, organ failure); 
however, this idea was not largely translated to clinical 
practice [4].
Sepsis definitions based on SIRS criteria have, though, 
been questioned as of late, as SIRS has been shown to be 
present in 93% of all patients admitted to intensive care 
(and therefore overly non-specific) [5]. Furthermore, up 
to 1 in every 8 patients with infection and organ dys-
function do not meet SIRS criteria [6]. Moreover, the 
methodology used to capture SIRS criteria may lead to 
substantial variability in defining sepsis cases [7, 8]. These 
and other concerns have led to the development and pub-
lication of new sepsis definitions (Sepsis-3), which were 
derived through a data-driven mortality risk stratification 
[9–11]. Although these new criteria have been validated 
in large databases, much controversy still surrounds 
them. Some criticisms include the new definitions’ lack 
of validation in scenarios outside of high-income coun-
tries, and their non-utilization of lactate as a marker of 
organ dysfunction [12–16].
Therefore, in order to address these concerns, we 
aimed to evaluate whether the new Sepsis-3 definitions 
maintain their accuracy in a different setting from those 
in which the criteria were developed and whether they 
can discriminate intensive care unit (ICU) mortality 
better than the previous definitions (Sepsis-2). We also 
evaluated whether the addition of lactate to the defini-
tions would improve upon the previous and new criteria’s 
accuracy of ICU mortality discrimination.
Methods
Study design, population and ethical requirements
This was a retrospective cohort study of patients diag-
nosed with sepsis admitted to an ICU over a 6-year 
span, from January 2010 to December 2015. Data were 
retrieved from the prospectively collected database of 
a 19-bed ICU in a Brazilian, academic, tertiary medical 
center in São Paulo—Brazil (Hospital das Clínicas, Uni-
versity of São Paulo Medical School). The study protocol 
followed the tenets of the Declaration of Helsinki. The 
institutional review board (Comissão para Análise de 
Projetos de Pesquisa—CAPPesq) reviewed and approved 
this study (CAPPesq—protocol number 107.443). Since 
the study was retrospective in nature and did not involve 
patient identification, informed consent was waived as 
there was no intervention.
Setting and sepsis management
Our ICU is located in the Hospital das Clínicas, the larg-
est healthcare complex in Latin America. At the time 
when the study was conducted, it consisted of seven 
specialized institutes, with a total of 2400 beds. In the 
Instituto Central, there are 7 ICUs, ours being mainly a 
Medical ICU, with patients from emergency surgery and 
trauma being admitted occasionally for logistical reasons.
The ICU is managed by staff as follows: one nursing 
assistant for every two beds; one nurse for every five 
beds; one respiratory therapist for every 10 beds; one 
staff physician for every 5–8 beds; and residents of inter-
nal medicine, critical care, physical therapy, nutrition and 
nursing. The studied ICU is classified as a strained unit as 
occupation rate has been above 95% since the beginning 
of the study period, and the mean SAPS 3 of the patients 
is 60 [17]. Neither quantitative resuscitation nor proto-
colized care is routinely used for sepsis management. 
Our approach to sepsis care is described in Additional 
file 1.
Data collection
Our database is an electronic health chart record fulfilled 
by physicians and respiratory therapists on a daily basis. 
Patients were selected using sepsis, severe sepsis or septic 
shock as an [All field] search term in the syndromic diag-
nosis fields of the database. Senior intensivists clinically 
adjudicated these diagnoses based on previous Sepsis-2 
consensus. Patients with any acute organ failure were 
considered to have severe sepsis, while septic shock was 
defined when patients were on vasopressors despite fluid 
resuscitation. These were adjudicated independent of the 
presence of 2 SIRS criteria. The following clinical data were 
collected: age; gender; worst and best vital signs during the 
first ICU day; Simplified Acute Physiological Score (SAPS) 
3; first day total Sequential Organ Failure Assessment 
(SOFA) score; syndromic diagnosis; etiological diagnosis; 
comorbidities; ICU length of stay (LOS); organ support 
measures; clinical ICU outcomes; and highest lactate level 
of the first day. Laboratory variables were retrieved from 
the electronic health database specific to laboratorial data.
Sepsis definitions
Sepsis-2 definitions were primarily used to classify our 
patients in the database. The categories (sepsis, severe 
sepsis and septic shock) were defined according to previ-
ously published consensus [4]. The new Sepsis-3 catego-
ries were defined as follows [9]:
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  • Infection without acute organ dysfunction (no-dys-
function category) infected patients with no signifi-
cant additional organ dysfunction over the previous 
conditions, that is, a variation of total SOFA <2 over 
baseline (chronic organ dysfunction) during the first 
24 h after ICU admission.
  • Sepsis (sepsis category) infected patients with a total 
SOFA variation ≥2 over baseline clinical condition.
  • Septic shock (septic shock category) infected patients 
with persistent hypotension [mean arterial blood 
pressure (MAP) <65  mmHg] after adequate fluid 
resuscitation needing vasopressors to keep MAP 
≥65  mmHg. Additionally, the hypotension or need 
for vasopressors must be associated with lactate level 
>2 mmol/L measured during the first 24 h.
Baseline total SOFA score was considered to be 4 in 
patients undergoing chronic dialysis, and 2 or 3 in cir-
rhotic patients, depending on baseline bilirubin levels. 
For instance, according to the Sepsis-3 definition [9], a 
patient with chronic renal failure undergoing dialysis was 
considered to be in the sepsis group only when the total 
SOFA score was ≥6. Although the original validation of 
Sepsis-3 definitions did not include patients with ICU 
LOS <2  days [9], we included all patients in the period 
described, independently of LOS, in order to pragmati-
cally test the definitions in our ICU.
Outcome
The primary outcome of interest was ICU mortality.
Statistical analysis
Continuous variables were assessed for normality using 
the Kolmogorov–Smirnov test. Parametric continu-
ous variables were compared between groups using the 
t test; nonparametric variables were compared using the 
Mann–Whitney test. Categorical variables were com-
pared between groups using the Chi-squared test.
We assessed the independent association between lac-
tate and outcome regardless of definition (both Sepsis-2 
and Sepsis-3) group using a logistic regression model. 
Six models were built, three for each definition consid-
ering three different cutoffs for lactate (as a continuous 
predictor, stratified at ≤2 or >2  mEq/L and at ≤4 and 
>4 mEq/L). Since serum lactate measurements were posi-
tively skewed, we used log transformation to fit it into the 
model as a continuous variable. We further assessed the 
independent association of Sepsis-3 category and lactate 
level after adjusting for age, severity at baseline (SAPS 3) 
and use of support measures (renal replacement therapy, 
mechanical ventilation). Demographic variables (age and 
sex) were selected based on univariate analysis, with p 
values < 0.2 used as cutoff. The other confounding vari-
ables were selected because of clinical relevance.
The effect of adding lactate (as a continuous variable 
or stratified at ≤2 or >2  mEq/L or at ≤4 or >4  mEq/L) 
on model performance was assessed through area 
under receiver operating characteristic curve (AUROC). 
AUROCs were compared using DeLong’s test. Addi-
tionally, we assessed the impact of adding lactate to the 
model using continuous net reclassification improve-
ment (NRI) and integrated discrimination index (IDI), as 
previously suggested [18]. NRI compares classifications 
from 2 models (in this case, with and without lactate) for 
changes by outcome for a net calculation of changes in 
the right correction. IDI integrates the NRI over all possi-
ble cutoffs and is equivalent to the difference in discrimi-
nation slopes. In this paper, based on the histograms of 
the probability of ICU mortality distributions, the cutoff 
values for reclassification were the following: <30; 30–60; 
and >60%. We do not report categorical NRI since no sin-
gle probability cutoff has been defined for the decision-
making process in caring for septic patients, as discussed 
in the Sepsis-3 consensus [10].
Missing values were handled as previously suggested 
for studies in critical care, when missing values are <5% 
[19]. There were 46 (<5%) missing lactate values of the 
first day, which were replaced by the first second day 
value, or by median imputation if there were not data 
available. All statistical analyses and graphs were done in 
R-free source software [20].
Results
The general characteristics of patients, as well as support 
measures, clinical outcomes, source of infection, and 
comorbidities are given in Table 1. For the whole group, 
mean age was 52 years, without gender differences. The 
most frequent infectious source was respiratory, fol-
lowed by abdominal and urinary tract sources. The most 
frequent comorbidities were diabetes, heart failure and 
hypertension. Sixty percentage of patients used vaso-
pressors; 44%, mechanical ventilation; and 24%, renal 
replacement therapy. ICU mortality was 32%. In univari-
ate analysis, non-survivors had higher mean age, severity 
at admission (SAPS 3), more organ dysfunctions (SOFA) 
and higher worst lactate values. No infectious source was 
associated with mortality, neither comorbidities, except 
for hematological cancer. They also presented more fre-
quently with septic shock when compared to other cat-
egories. Furthermore, invasive support measures were 
more frequently used in this population.
Figure 1 depicts that Sepsis-2 definitions show reasona-
ble differentiation in mortality only between septic shock 
and severe sepsis patients, while Sepsis-3 definitions 
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Age—yo 52 ± 19 50 ± 19 56 ± 18 <0.001
Gender (males/females)—n 504/453 331/315 173/138 0.291
SAPS 3 65 [50,79] 60 [48,72] 74 [59,90] <0.001
Total SOFA (first day) 6 [3,9] 5 [3,8] 9 [6,12] <0.001
Worst lactate (first day)—mmol/L 3.0 [2.0,4.0] 2.7 [1.9,3.7] 3.7 [2.2,5.8] <0.001
Maximum SOFA (ICU stay) 7 [6,12] 6 [5,9] 12 [8,16] <0.001
Support measures
Vasopressors—n (%) 572 (60) 322 (50) 250 (80) <0.001
Inotropes—n (%) 13 (1) 11 (2) 2 (1) <0.001
Mechanical ventilation (first day)—n (%) 259 (27) 131 (20) 128 (41) <0.001
(C)RRT (first day)—n (%) 102 (11) 51 (8) 51 (16) <0.001
Mechanical ventilation (ICU stay)—n (%) 420 (44) 267 (41) 153 (49) 0.026
(C)RRT (ICU stay)—n (%) 233 (24) 137 (21) 96 (31) 0.001
Sepsis-2 classification
Sepsis—n (%) 134 (14) 116 (18) 18 (6) <0.001
Severe sepsis—n (%) 251 (26) 208 (32) 43 (14) <0.001
Septic shock—n (%) 572 (60) 322 (50) 250 (80) <0.001
Sepsis-3 classification
No-dysfunction—n (%) 103 (11) 96 (15) 7 (2) <0.001
Sepsis—n (%) 419 (44) 313 (48) 106 (34) <0.001
Septic shock—n (%) 435 (45) 237 (37) 198 (64) <0.001
Infection source
Respiratory—n (%) 402 (42) 263 (41) 139 (45) 0.271
Abdominal—n (%) 107 (11) 75 (12) 32 (10) 0.619
Urinary tract—n (%) 84 (9) 63 (10) 21 (7) 0.157
Skin and soft tissue—n (%) 72 (8) 45 (7) 27 (9) 0.417
Febrile neutropenia syndrome—n (%) 32 (3) 19 (3) 13 (4) 0.420
Catheter related—n (%) 22 (2) 17 (3) 5 (2) 0.448
Primary bloodstream infection—n (%) 17 (2) 13 (2) 4 (1) 0.592
Osteoarticular—n (%) 17 (2) 10 (2) 7 (2) 0.610
Unidentifiable source—n (%) 167 (17) 117 (18) 50 (16) 0.493
Othersb—n (%) 37 (4) 24 (4) 13 (4) 1.000
Comorbidities
Diabetes mellitus—n (%) 196 (20) 124 (19) 72 (23) 0.174
Chronic heart failure—n (%) 107 (11) 71 (11) 36 (12) 0.860
Chronic arterial hypertension—n (%) 95 (10) 61 (9) 34 (11) 0.534
Dialysis dependent chronic renal failure—n (%) 66 (7) 48 (7) 18 (6) 0.429
Rheumatologic diseases—n (%) 59 (6) 37 (6) 22 (7) 0.497
Chronic obstructive pulmonary disease—n (%) 38 (4) 25 (4) 13 (4) 0.949
Hematologic cancer—n (%) 30 (3) 11 (2) 19 (6) <0.001
Solid cancer—n (%) 26 (3) 17 (3) 9 (3) 0.977
Organ transplantation—n (%) 20 (2) 14 (2) 6 (2) 1.000
AIDSc—n (%) 19 (2) 12 (2) 7 (2) 0.867
Liver cirrhosis—n (%) 14 (1) 9 (1) 5 (2) 1.000
Outcomes
Days on mechanical ventilationd 3 [1,6] 3 [1,6] 3 [1,4] 0.716
Days on (C)RRTd 3 [2,7] 3 [2,7] 3 [2,6] 0.181
Days on vasopressorsd 2 [1,4] 2 [1,4] 2 [1,4] 0.991
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show clear stratification of mortality among the three 
categories (no-dysfunction, sepsis and septic shock). 
Additional file  2: Table  1s shows patients’ re-allocation 
between both sepsis definitions. Sepsis-3 classification 
reduced the percentage of septic shock patients as com-
pared to the previous definition.
Additional file  3: Figure  1s shows the median lactate 
levels of each sepsis category in both sepsis definitions. 
Significant differences between lactate levels occurred 
only in the septic shock categories for both definitions 
(Panels A and C) and between survivors and non-sur-
vivors in both septic shock definitions (Panels B and D). 
The mortality rates according to the sepsis definitions, 
sepsis categories and serum lactate concentrations are 
shown in Additional file 4: Fig. 2s. Lactate levels higher 
than 2  mmol/L were not clearly discriminative of mor-
tality in the Sepsis-2 defined categories of severe sepsis 
or septic shock. In comparison, lactate levels >4 mmol/L 
clearly marked increased mortality in both the severe 
sepsis and septic shock categories of Sepsis-2 and in the 
no-dysfunction and septic shock categories of Sepsis-3.
 Table 2 shows the associations of sepsis definitions with 
mortality and the additional impact of lactate inclusion in 
the multivariate model. Furthermore, Table  3 shows the 
association of Sepsis-3 definition with ICU mortality, after 









ICU Length of stay—days 5 [4,11] 5 [4,10] 6 [3,13] 0.994
ICU mortality—n (%) 311 (32) 0 (0) 311 (100) na
Death within the first 48 h of ICU—n (%) 78 (8) 0 (0) 78 (25) na
Discharge within the first 48 h of ICU—n (%) 85 (9) 85 (13) 0 (0) na
a Comparison between survivors and non-survivors
b Others are endocarditis, meningitis, leptospirosis and mediastinitis
c AIDS denotes acquired immunodeficiency syndrome
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P = 0.430 
P < 0.001 
P < 0.001 
P < 0.001 
P < 0.001 
P < 0.001 
Fig. 1 Mortality stratified according to sepsis definition. a Mortality according to the Sepsis-2 definition (Pearson’s Chi-squared test using the three 
categories P < 0.001. Pearson’s Chi-squared post hoc analyses are shown in the figure). b Mortality according to the Sepsis-3 definition (Pearson’s 
Chi-squared test using the three categories P < 0.001. Pearson’s Chi-squared post hoc analyses are shown in the figure)
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through SAPS 3), requirement for RRT and mechanical 
ventilation at any time of ICU stay. 
Table 4 shows the accuracy of ICU death prediction of 
models using only the sepsis definitions and sepsis defini-
tions added to lactate as a continuous and dichotomous 
variable. The accuracy significantly improved with the 
addition of lactate to the model.
Further evaluation of lactate’s addition to the sepsis 
definitions model using the net reclassification index 
(NRI) and integrated discrimination increment (IDI) 
is presented in Additional file  2: Table  2s. In Sepsis-2 
definitions, NRI as it relates to ICU mortality was 23.1 
(P  <  0.001) for lactate >2  mmol/L and 39.9 (P  <  0.001) 
for lactate >4 mmol/L. For Sepsis-3 definitions, NRI was 
39.9 (P  <  0.001) for lactate levels >4  mmol/L. The dis-
crimination slope of the updated model with lactate lev-
els >4 mmol/L, as assessed by IDI, was 3.3 (P < 0.001) for 
Sepsis-2 and 2.7 (P < 0.001) for Sepsis-3. For lactate levels 
>2 mmol/L, IDI was 0.7 (P = 0.021) for Sepsis-2 criteria, 
while it was not significant for Sepsis-3.
Table 2 Multivariate models using ICU death as a dependent variable and sepsis definition and lactate as independent 
variables
This analysis was performed using a binary logistic regression. The first model used lactate as a continuous variable (after logarithmic transformation in order to 
correct the positive skewness); the second and third models used lactate as a categorical variable
Lactate > 2 mmol/L represents all patients with lactate > 2 mmol/L, including those with lactate > 4 mmol/L
Lactate as a continuous variable Lactate > 2 mmol/L Lactate > 4 mmol/L
OR (CI 95%) P value OR (CI 95%) P value OR (CI 95%) P value
Sepsis-2 model
Sepsis 1 Reference 1 Reference 1 Reference
Severe sepsis 1.06 (0.97–1.16) 0.322 1.03 (1.01–1.19) 0.500 1.04 (0.95–1.19) 0.342
Septic shock 1.34 (1.22–1.44) <0.001 1.33 (1.22–1.45) 0.001 1.32 (1.21–1.43) 0.001
Lactate 1.02 (1.02–1.03) 0.001 1.07 (1.00–1.14) 0.027 1.21 (1.14–1.30) 0.001
Sepsis-3 model
No-dysfunction 1 Reference 1 Reference 1 Reference
Sepsis 1.21 (1.11–1.34) <0.001 1.19 (1.08–1.32) <0.001 1.21 (1.10–1.14) <0.001
Septic shock 1.41 (1.28–1.56) <0.001 1.49 (1.35–1.65) <0.001 1.41 (1.28–1.56) <0.001
Lactate 1.02 (1.01–1.03) <0.001 0.97 (0.90–1.05) 0.466 1.19 (1.11–1.28) <0.001
Table 3 Multivariate models using ICU death as  a dependent variable and  Sepsis-3 definition, lactate, age, SAPS 3 
and requirement for RRT and mechanical ventilation as independent variables
a Support needed at any time of ICU stay; RRT renal replacement therapy; SAPS Simplified Acute Physiological Score
b AUC area under the curve
Lactate as a continuous variable Lactate > 2 mmol/L Lactate > 4 mmol/L
OR (CI 95%) P value OR (CI 95%) P value OR (CI 95%) P value
Sepsis-3 model
No-dysfunction 1 Reference 1 Reference 1 Reference
Sepsis 3.70 (1.75–9.12) 0.002 3.35 (1.57–8.27) 0.004 3.67 (1.73–9.07) 0.002
Septic shock 6.21 (2.94–15.27) <0.001 7.31 (3.41–18.22) <0.001 6.22 (2.94–15.31) <0.001
Lactate 1.11 (1.06–1.16) <0.001 0.94 (0.60–1.48) 0.811 2.28 (1.61–3.24) <0.001
Age 1.01 (1.01–1.02) <0.001 1.01 (1.01–1.02) 0.002 1.01 (1.00–1.02) <0.001
SAPS 3 1.02 (1.01–1.03) <0.001 1.02 (1.01–1.03) <0.001 1.02 (1.01–1.03) <0.001
RRTa 1.63 (1.15–2.31) 0.006 1.56 (1.11–2.21) 0.011 1.66 (1.17–2.36) 0.004













Model accuracy 0.732 (0.698–0.766) <0.001 0.725 (0.691–0.759) <0.001 0.732 (0.698–0.766) <0.001
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Discussion
In this study, we demonstrate that Sepsis-3 is better than 
Sepsis-2 at stratifying mortality among septic patients 
admitted in a strained ICU of a developing country. Sep-
sis-3 criteria clearly categorized septic patients along a 
spectrum of severity, since mortality increased from 7% 
in no-dysfunction-infected patients to 25 and 46% for 
sepsis and septic shock patients, respectively. In contrast, 
in the Sepsis-2 definitions, only the septic shock criterion 
was associated with a significantly higher mortality when 
compared to the severe sepsis and sepsis categories (44, 
17 and 13%, respectively). Moreover, a lactate level higher 
than 4 mmol/L improved the mortality prediction accu-
racy on both Sepsis-2 and Sepsis-3 definitions (Table 3).
The validity of sepsis definitions based on SIRS crite-
ria has recently been called into question. This is because 
almost 90% of the patients admitted to an intensive care 
unit (ICU) meet the SIRS criteria, [5, 21]. Even SIRS 
criteria’s high sensitivity has been questioned recently, 
as some patients with known infectious insult and new 
organ failures do not satisfy 2 SIRS criteria and therefore 
do not fulfill previous sepsis definitions [6]. Even more 
importantly, the categories of sepsis, severe sepsis and 
septic shock should indicate a real spectrum of severity 
to be considered as different outcome categories [14]. 
The present study reinforces a lack of accuracy of Sep-
sis-2 definitions of sepsis, severe sepsis and septic shock 
in stratifying patients’ mortality risk. Additionally, our 
data demonstrate Sepsis-3 definitions of infection with-
out organ dysfunction, sepsis and septic shock clearly 
represent progressive strata of mortality risk (Fig. 1).
High lactate values in sepsis may be the result of per-
fusion abnormalities or stress hyperlactatemia [22]. 
Regardless of the reason for its increase, early high lac-
tate value is traditionally associated with worse outcomes 
in septic [23] and other critically ill patients [24, 25]. The 
fact that lactate was not maintained as a marker of organ 
dysfunction in the new sepsis definitions raised several 
concerns [26, 27], and the Surviving Sepsis Campaign 
suggested that lactate should continue to be measured 
to identify dysfunction [27]. In the original validation 
study of Sepsis-3 definitions, although high lactate levels 
were associated with higher mortality at different cutoffs 
regardless of hypotension or vasopressors, lactate was 
retained only for the characterization of septic shock [9]. 
In the present study, however, lactate was a prognostic 
factor for both definitions and reclassified some Sepsis-
3-defined patients when its levels were above 4 mmol/L. 
In the assessment of the new septic shock definitions in 
the original validation study, lactate levels higher than 
2 mmol/L were increasingly associated with higher odds 
of death [11]. In our study, cutoff levels above 2 mmol/L 
did not add any prognostic information in this stratum of 
severity, as expected, because it is included in the defi-
nition itself. However, in accordance with the validation 
paper, higher lactate levels (which we chose to add in the 
model as >4 mmol/L) were of prognostic significance.
In the validation of clinical criteria for sepsis, unfor-
tunately, there was no clear mention to the added 
benefit of lactate for patients with SOFA scores <2, 
possibly because of lactate values missingness in the 
derivation (about 60%) and validation cohorts (about 
90%) [10]. Interestingly, lactate was not retained in the 
novel qSOFA during model construction. However, the 
authors state that for a qSOFA score of 1, high lactate 
values characterized a population with similar risk to 
patients with a qSOFA score of 2 [10]. In our cohort, 
for patients without organ dysfunction, lactate levels 
higher than 4 mmol/L seem to categorize a population 
at higher risk of death (Table  2 and Additional file  4: 
Fig.  2s). Therefore, high lactate levels in patients with-
out organ dysfunction as assessed by the SOFA score 
Table 4 Predictive accuracy of mortality of sepsis definitions with or without lactate value
The receiver operating curves (ROC) were constructed using the binary logistic regression probabilities of death using sepsis definitions and lactate categories. AUC 
area under the ROC curve
a Lactate as a continuous variable was logarithmically transformed in order to correct the positive skewness. Lactate > 2 mmol/L represents all patients with 
lactate > 2 mmol/L, including those with lactate > 4 mmol/L
b DeLong’s test P < 0.05 versus without lactate model
c DeLong’s test P = ns versus lactate as a continuous variable
d DeLong’s test P < 0.05 versus lactate > 2 mmol/L
Sepsis-2 definition Sepsis-3 definition
AUC (CI 95%) Asymptotic P value AUC (CI 95%) Asymptotic P value
Without lactate model 0.650 (0.619–0.680) <0.001 0.615 (0.580–0.650) <0.001
Lactate as a continuous variablea 0.704 (0.668–0.739)b <0.001 0.649 (0.608–0.689)b, d <0.001
Lactate > 2 mmol/L 0.664 (0.631–0.697) <0.001 0.620 (0.584–0.656) <0.001
Lactate > 4 mmol/L 0.686 (0.653–0.719)b, c, d <0.001 0.636 (0.598–0.674)b, c, d <0.001
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might improve risk stratification and change manage-
ment of these patients, since they could be allocated to 
a higher level of care upfront in order to avoid further 
deterioration of their clinical status.
Sepsis-3 criteria for identifying septic patients have 
been extensively questioned since its publication [12, 15]. 
A possible decrease in awareness of sepsis and a need for 
massive educational programs to healthcare providers are 
among the main concerns. In this context, how Sepsis-3 
criteria would perform for sepsis detection, especially in 
countries with high mortality rates, still needs validation. 
Our study was not designed to assess Sepsis-2 or Sepsis-3 
as a screening tool, since only patients admitted to ICU 
were included. The role of Sepsis-2 criteria for identifying 
septic patients is undeniable, as was the case in a recent 
before–after study conducted in Brazil [28]. However, 
its accuracy to stratify severity can be called into ques-
tion, as demonstrated by our data. Accordingly, our study 
clearly shows a better discriminative performance of Sep-
sis-3 in predicting ICU mortality.
Strengths of this study include the number of patients 
analyzed, the recent timeframe and the use of statistical 
methodologies such as net reclassification index, which 
allowed us to better evaluate the benefit of adding lac-
tate to the new definition. Also, NRI was not used in the 
original validation study and our data missingness for 
lactate values was much lower (<5%), which could have 
yielded some of the above different results. Furthermore, 
this represents an external assessment of new criteria in 
a different setting than that of the original validation—an 
important step toward consistency for its findings.
There are, nevertheless, several limitations to be 
addressed, in light of which our findings should be inter-
preted. First, the retrospective nature of this study makes 
it difficult to elucidate known confounders that could 
have biased the outcome measures, such as differences in 
sepsis treatment. Second, this was a single-center study 
consisting mainly of medical patients and our results 
may not be generalizable to other centers, including from 
other developing countries, since there is wide variation 
in outcomes even within Brazil when comparing differ-
ent settings [29, 30]. Third, we evaluated only patients 
admitted to the ICU and, therefore, our findings cannot 
be extrapolated to patients treated in wards and in the 
emergency room. This also threatens the generalizability 
of our results, since the original study captured a popula-
tion with presumed infection not only in the ICU. Fourth, 
the validity of Sepsis-3 criteria in this study was assessed 
based on ICU mortality. Although ICU mortality is not 
the most appropriate endpoint to be evaluated, it reflects 
the pre-ICU and ICU care of septic patients, and in our 
scenario, identified a more specific point to improve the 
care of septic patients [31, 32].
Conclusions
The new clinical criteria of sepsis proposed by the third 
international consensus (Sepsis-3) could predict mortal-
ity in infected patients admitted to a strained ICU in a 
middle-income country. The prognostic value of the new 
definition of sepsis was progressive along all three cate-
gories, which denotes a spectrum of gravity of infectious 
process and could help in risk stratification for future 
studies in this area of research. This was not observed 
of the previous definitions (Sepsis-2) in our sample. 
Serum lactate improved accuracy for values higher than 
4 mmol/L in the no-dysfunction and septic shock groups.
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Additional file 3: Figure 1s Lactate levels according to the sepsis cat-
egories. Panel A shows lactate levels according to the Sepsis-2 definition. 
Panel B shows lactate levels according to the Sepsis-2 definition, strati-
fied according to survival. Panel C shows lactate levels according to the 
Sepsis-3 definition. Panel D shows lactate levels according to the Sepsis-3 
definition, stratified according to survival. * Kruskal-Wallis’ test P < 0.001 
among the three sepsis categories. Mann-Whitney’s P < 0.05 post-hoc 
analysis vs. other categories. # Mann-Whitney’s test P < 0.05 vs. survivors.
Additional file 4: Figure 2s Mortality according to the sepsis category 
and lactate concentration. Panel A shows the Sepsis-2 categories. Panel B 
shows the Sepsis-3 categories. Lactate > 2 mmol/L represents all patients 
with lactate > 2 mmol/L, including those with lactate > 4 mmol/L* 
Number of patients in the category. # Pearson’s Chi-squared test P < 
0.001 among the three sepsis categories (same lactate level). Pearson’s 
Chi-squared test P < 0.05 post-hoc analysis vs. severe sepsis (same lactate 
level) category.$ Pearson’s Chi-squared test P < 0.001 among the three 
sepsis categories (same lactate level). Pearson’s Chi-squared test P < 0.05 
post-hoc analysis vs. sepsis (same lactate level) category. % Pearson’s 
Chi-squared test P < 0.001 among the three lactate categories (same 
sepsis category level). Pearson’s Chi-squared test P < 0.05 post-hoc analysis 
vs. whole group and Lactate > 2 mmol/L (same sepsis category level) 
categories.
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